Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Swiss study aims to unlock secrets of pandemic spread

NCT ID NCT06739499

Knowledge-focused Sponsor: University of Bern Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows over 2,000 people and their pets in the Canton of Bern to learn how infections like COVID-19 spread and what social and environmental factors influence transmission. Participants provide samples and answer questionnaires over time. The goal is to improve pandemic preparedness, not to test any treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could provide valuable insights into how infections spread and what factors affect pandemic preparedness, helping communities better respond to future outbreaks.
What could go wrong
This is an observational study, not a treatment trial. It cannot directly prevent or cure disease, and results may not apply to other regions or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

2,157 people

The number who actually took part.

Started

Apr 2024

Expected to finish

Dec 2100

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

BEready will include a spectrum of the Bernese population living in private households, including adults, children and pets. A private household is defined as a person living alone or group of persons living in the same dwelling. The study population for the BEready cohort will be enrolled from different sources in the source population of the canton of Bern. BEready aims to enrol around 1,500 households in total from: * Households already participating in the BEready pilot study * A random selection of households in Bern using the cantonal residents' register * Volunteer households from the general public

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria for adults and children: * Informed consent * Residence (average of more than 3 days/week) in a private household in the canton of Bern where at least one member aged 18 agreed to take part. * For adults, children aged 14 years or older, and parents/legal guardians: internet connection (Wi-Fi, fixed or on a mobile phone) and personal email address. * For adults, children aged 11 years or older, and parents/legal guardians: able to understand, speak, read and write German, French and/or English. Inclusion criteria for household pets: Pets of eligible household members with the consent of their owners. Exclusion criteria for adults and children: Currently planned move outside the canton of Bern

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Epidemic disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

COVID-19 Infections infectious disease respiratory tract infectious disorder Zoonoses

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Epidemic disease Infections Pandemic, COVID-19 Respiratory tract infections Zoonoses

Contacts and locations

Locations

  • University of Bern

    Bern, 3012, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.